These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31473490)
41. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. DeGrado TR; Baldwin SW; Wang S; Orr MD; Liao RP; Friedman HS; Reiman R; Price DT; Coleman RE J Nucl Med; 2001 Dec; 42(12):1805-14. PubMed ID: 11752077 [TBL] [Abstract][Full Text] [Related]
42. Dual-phase (18)F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan. Tong AK; Zhang ZX; Zaheer S; Yan XS Clin Imaging; 2016; 40(3):486-91. PubMed ID: 27133692 [TBL] [Abstract][Full Text] [Related]
43. Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis. Wyss MT; Spaeth N; Biollaz G; Pahnke J; Alessi P; Trachsel E; Treyer V; Weber B; Neri D; Buck A J Nucl Med; 2007 Apr; 48(4):608-14. PubMed ID: 17401099 [TBL] [Abstract][Full Text] [Related]
45. Radiation dosimetry of 18F-fluorocholine PET/CT studies in prostate cancer patients. Fabbri C; Galassi R; Moretti A; Sintuzzi E; Mautone V; Sarti G; Strigari L; Benassi M; Matteucci F Phys Med; 2014 May; 30(3):346-51. PubMed ID: 24238928 [TBL] [Abstract][Full Text] [Related]
46. Transcriptomics Associates Molecular Features with Kwee SA; Tiirikainen M; Sato MM; Acoba JD; Wei R; Jia W; Le Marchand L; Wong LL Cancer Res; 2019 Apr; 79(7):1696-1704. PubMed ID: 30760520 [TBL] [Abstract][Full Text] [Related]
47. A rapid and systematic approach for the optimization of radio thin-layer chromatography resolution. Laferriere-Holloway TS; Rios A; Lu Y; Okoro CC; van Dam RM J Chromatogr A; 2023 Jan; 1687():463656. PubMed ID: 36463649 [TBL] [Abstract][Full Text] [Related]
48. Radiosynthesis and pre-clinical evaluation of [(18)F]fluoro-[1,2-(2)H(4)]choline. Smith G; Zhao Y; Leyton J; Shan B; Nguyen QD; Perumal M; Turton D; Årstad E; Luthra SK; Robins EG; Aboagye EO Nucl Med Biol; 2011 Jan; 38(1):39-51. PubMed ID: 21220128 [TBL] [Abstract][Full Text] [Related]
50. Metabolism of a Bioorthogonal PET Tracer Candidate [ Otaru S; Niemikoski H; Sarparanta M; Airaksinen AJ Mol Pharm; 2020 Aug; 17(8):3106-3115. PubMed ID: 32539414 [TBL] [Abstract][Full Text] [Related]
51. Quantitative radio-thin-layer chromatography and positron emission tomography studies for measuring streptavidin transduced chimeric antigen receptor T cells. Liu J; Xu N; Wang X; Wang Y; Wu Q; Li X; Pan D; Wang L; Xu Y; Yan J; Li X; Yu L; Yang M J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122944. PubMed ID: 34592686 [TBL] [Abstract][Full Text] [Related]
52. Quantitative Schaefferkoetter JD; Wang Z; Stephenson MC; Roy S; Conti M; Eriksson L; Townsend DW; Thamboo T; Chiong E EJNMMI Res; 2017 Dec; 7(1):25. PubMed ID: 28324340 [TBL] [Abstract][Full Text] [Related]
53. Fluorocholine PET/computed tomography: physiologic uptake, benign findings, and pitfalls. Beheshti M; Haroon A; Bomanji JB; Langsteger W PET Clin; 2014 Jul; 9(3):299-306. PubMed ID: 25030393 [TBL] [Abstract][Full Text] [Related]
54. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine. Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231 [TBL] [Abstract][Full Text] [Related]
55. 18F-Fluorocholine PET/CT in the Prediction of Molecular Subtypes and Prognosis for Gliomas. García Vicente AM; Pérez-Beteta J; Amo-Salas M; Pena Pardo FJ; Villena Martín M; Sandoval Valencia H; Mollejo Villanueva M; Barbella R; Klein Zampaña CJ; Borrás Moreno JM; Soriano Castrejón ÁM; Pérez-García VM Clin Nucl Med; 2019 Oct; 44(10):e548-e558. PubMed ID: 31306196 [TBL] [Abstract][Full Text] [Related]
56. Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats. Schou M; Zoghbi SS; Shetty HU; Shchukin E; Liow JS; Hong J; Andrée BA; Gulyás B; Farde L; Innis RB; Pike VW; Halldin C Mol Imaging Biol; 2009; 11(1):23-30. PubMed ID: 18800204 [TBL] [Abstract][Full Text] [Related]
57. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma. Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307 [TBL] [Abstract][Full Text] [Related]
58. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560 [TBL] [Abstract][Full Text] [Related]
59. Preparation and evaluation of ethyl [(18)F]fluoroacetate as a proradiotracer of [(18)F]fluoroacetate for the measurement of glial metabolism by PET. Mori T; Sun LQ; Kobayashi M; Kiyono Y; Okazawa H; Furukawa T; Kawashima H; Welch MJ; Fujibayashi Y Nucl Med Biol; 2009 Feb; 36(2):155-62. PubMed ID: 19217527 [TBL] [Abstract][Full Text] [Related]